featured
Talazoparib in Patients With a Germline BRCA-Mutated Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Talazoparib in Patients With a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses From the Phase III EMBRACA Trial
Oncologist 2019 Nov 25;[EPub Ahead of Print], SA Hurvitz, A Gonçalves, HS Rugo, KH Lee, L Fehrenbacher, LA Mina, S Diab, JL Blum, J Chakrabarti, M Elmeliegy, L DeAnnuntis, E Gauthier, A Czibere, IC Tudor, RGW Quek, JK Litton, J EttlFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.